BETAHIST 16

BETAHIST-16 Tablet contains the active substance Betahistine and is mainly indicated for alleviating symptoms associated with vertigo resulting from inner ear disorders. Vertigo is a condition that leads to a sensation of spinning or dizziness, often accompanied by balance disruptions. Betahistine functions by enhancing blood circulation within the inner ear, which can help diminish both the intensity and frequency of vertiginous episodes. The medication is thought to assist in normalizing the operation of the inner ear, thereby leading to a decrease in associated symptoms such as dizziness, lightheadedness, and nausea. This pharmaceutical formulation is provided in a tablet format for oral administration, which may be taken with or without meals. The prescribed dosage typically varies based on the individual’s symptom severity and their response to treatment. It is important for patients to follow their healthcare provider’s recommendations regarding dosage and administration to achieve optimal results and to manage their symptoms effectively. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.